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Abstract Breast cancer is the leading causeof cancerdeaths inwomen.Recent advances innanomedicinehave shown
that gold nanorods (AuNRs), as multifunctional drug delivery and photothermal therapeutic agents, have
potential for use in cancer therapy. However, the effect of AuNRs on the transcriptome of breast cancer cells
is unknown. In the present study, cells of the triple-negative human breast cancer cell line MDA-MB-231,
which has high metastatic activity, were treated with AuNRs for transcriptomic analysis using RNA-seq
technology. In total, 3126 genes were found to be up-regulated and 3558 genes were found to be down-
regulated inAuNR-treatedMDA-MB-231cells. Thesedifferentially expressedgenespresumably takepart in
multiple biological pathways, including glycolysis and regulation of the actin cytoskeleton, and impact a
variety of cellular functions, including chemoattractant activity. The distinct gene expression proﬁle of
MDA-MB-231 cells treated with AuNRs provides a foundation for further screening and validation of
important genes involved in the interaction between AuNRs and MDA-MB-231 cells.
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INTRODUCTION
Breast cancer, a type of cancer originating from breast
tissue, is the most common cancer in women and is the
second leading cause of cancer death in women (Kreiter
et al. 2014). Breast cancer can also occur in men, who
tend to have poorer outcomes due to delays in diagnosis
(Block and Muradali 2013). Prognosis and survival rates
for breast cancer vary greatly depending on the cancer
type, stage, treatment, and geographical location of the
patient. Determining the presence of estrogen and
progesterone receptors in breast cancer cells is impor-
tant for guiding hormone therapy (Lavrovskaya et al.
2005). In addition to hormone receptors, other cell
surface proteins, such as HER2, may affect prognosis
and treatment. Patients who test positive for HER2 may
be treated with trastuzumab (Herceptin), a monoclonal
antibody that targets HER2 and signiﬁcantly improves
patient prognosis (Mariani et al. 2009). Cancers that test
negative for these hormone receptors and for HER2 are
not able to respond to hormone therapy or monoclonal
antibody therapy, and patients with those cancers have
a lower chance of survival (Kim et al. 2014).
Currently, researchers are pursuing the development
of new tools and therapeutic strategies to provide more
effective therapies against cancers including triple-
negative breast cancers. Recent advances in nanomedi-
cine, a multidisciplinary ﬁeld that involves the
application of nanomaterials in medicine and healthcare,
offer a promising alternative for cancer treatment (Farrell
et al. 2010; Alexis et al. 2010; Sahoo et al. 2007). Due to
their small size and the fact that they can be easily
modiﬁed, nanomaterials demonstrate signiﬁcant advan-
tages in gaining access to cancer cells, by either passive
or active targeting. In addition, based on their unique
intrinsic characteristics and controlled functional prop-
erties, nanomaterials have the potential for broad& Correspondence: weitt@moon.ibp.ac.cn (T. Wei)
106 | October 2015 | Volume 1 | Issue 2  The Author(s) 2015. This article is published with open access at Springerlink.com
Biophys Rep 2015, 1(2):106–114
DOI 10.1007/s41048-015-0005-0 Biophysics Reports
application in the detection and imaging of cancers and
in cancer therapy (Tiwari 2012; Bae et al. 2011; Zhang
et al. 2008). Among these nanomaterials, gold nanorods
(AuNRs) have been widely examined for applications in
bioimaging, biosensing, drug delivery, and photothermal
therapy due to their unique physiochemical and optical
properties (Wang et al. 2014; Vigderman et al. 2012;
Jokerst et al. 2012; Alkilany et al. 2012; Cobley et al.
2011). To date, many studies have been performed on the
cytotoxicity, biocompatibility, and biodistribution of
AuNRs with different sizes, shapes, and surface modiﬁ-
cations (Zhang et al. 2013; Albanese et al. 2012; Gra-
binski et al. 2011; Qiu et al. 2010). Wang et al.
investigated the interaction between speciﬁc proteins
and AuNRs and determined the binding structure of the
protein corona on AuNRs (Wang et al. 2013). Zhang
et al. have suggested that AuNR exposure causes sig-
niﬁcant changes to the metabolome in human alveolar
epithelial carcinoma cells (Zhang et al. 2013). So far,
little is known regarding the effect of AuNRs on the
transcriptome of cancer cells.
The recent developments of next-generation sequencing
(NGS) allow us to sequence DNA and RNA with higher
sample throughput (Siu et al. 2011). Transcriptomic analy-
sis, which studies all of the RNA transcripts under a par-
ticular physiological condition, has played a central role in
detecting gene expression and transcriptional regulation
(Maher et al. 2009). RNA-seq technology, which uses deep-
sequencing technologies to directly determine cDNA
sequences, is an excellent approach for transcrip-
tome proﬁling (Costa et al. 2010). Because of its
relatively lower price, higher base coverage, and
greater precision with measuring transcripts com-
pared with hybridization-based microarray assays,
RNA-seq is particularly suited for the detection of
transcripts, which correspond to existing genomic
sequences (Wang et al. 2009). Curtis et al. have
recently revealed novel breast cancer subgroups
and their molecular drivers through genomic and
transcriptomic analysis (Curtis et al. 2012). However,
the transcriptomic changes of breast cancer cells
treated with AuNRs have not been investigated until
now.
In this study,weusedRNA-seq technology to investigate
the mRNA transcript changes in MDA-MB-231 human
breast cancer cells treated with AuNRs. The uptake of
AuNRs into MDA-MB-231 cells was observed using two-
photon laser confocal microscopy. Total mRNA samples
fromAuNR-treatedanduntreatedMDA-MB-231 cellswere
extracted, and a cDNA library for each sample was con-
structed. After Illumina HiSeqTM 2000 sequencing, com-
parative transcriptome analysis was performed to reveal
differentially expressed genes and related cellular func-
tions and pathways in AuNR-treated MDA-MB-231 cells.
RESULTS AND DISCUSSION
Uptake of AuNRs into MDA-MB-231 human
breast cancer cells
AuNRs were prepared according to previously descri-
bed procedures (Wang et al. 2011). The mean size of the
AuNRs was calculated by measuring at least 100 parti-
cles using transmission electron microscopy (TEM). The
AuNRs had an aspect ratio of 4.2 with a mean length of
51.2 ± 5.9 nm and a width of 12.2 ± 1.5 nm (Fig. 1A).
The cellular uptake and trafﬁcking of AuNRs are com-
plex processes composed of multiple pathways of
varying types (Zhang et al. 2013; Sahay et al. 2010;
Doherty and McMahon 2009). To visualize the uptake of
AuNRs by MDA-MB-231 cells, the cells were treated
with 50 lmol/L AuNRs for 24 h and observed under a
two-photon ﬂuorescence confocal microscope. As
shown in Fig. 1B, the AuNRs exhibited highly efﬁcient
two-photon-induced luminescence, which clearly indi-
cated the intracellular location of AuNRs in the cells.
AuNR exposure caused no signiﬁcant effects on the cell
viability, as measured by the MTT assay (data not
shown).
Construction of transcriptome proﬁles
To assess global transcriptome changes in the MDA-MB-
231 cells treated with AuNRs, the cells were treated
with 50 lmol/L AuNRs for 24 h or were not treated
(control). Then, an mRNA of each sample was extracted,
a cDNA library of each sample was constructed, and
Illumina sequencing was carried out as described above.
In total, 37,576,176 and 47,340,538 100 bp sequence
reads for the untreated cells (UT) and AuNR-treated
cells (AT), respectively, were generated by Illumina
HiSeqTM 2000 sequencing. The mean quality values and
statistical distributions of the reads obtained were cal-
culated to analyze the average data quality. As shown in
Table 1, more than 98% of the reads of each sample had
a mean quality value of at least 21, which indicated that
these data were reliable and that the following analyses
could be performed.
Next, the low-quality reads were ﬁltered, and the
remaining reads were used for the additional mapping
steps. In the UT library, 30,346,180 reads were mapped
to the Human Ensembl database or exon junction
database, of which 23,852,032 were focused on a
Transcriptomic analysis of human breast cancer cells treated with AuNRs RESEARCH ARTICLE
 The Author(s) 2015. This article is published with open access at Springerlink.com 107 | October 2015 | Volume 1 | Issue 2
unique region. In contrast, in the AT library, 38,140,036
reads were mapped to the Human Ensembl database or
exon junction database, of which 30,002,220 were
focused on a unique region. Both total mapping rates of
the two libraries were approximately 80%. Reads
mapping to the unique region were used to analyze the
distribution of the transcripts. In the two libraries, we
found that 60.38%–58.94% of the transcripts were
located in an exon region, 10.04%–10.88% of the tran-
scripts were in an intron region, and 0.28%–0.25% of
the transcripts were in an exon-intron region (Table 2).
Furthermore, the gene expression level was quanti-
ﬁed based on the number of reads that matched with
exon regions. For both the UT and AT samples, approx-
imately 35% of the identiﬁed transcripts had an RPKM
value\0.5, 65% of the transcripts had an RPKM value
more than 0.5, and 5% of the transcripts had an RPKM
value [50 (Fig. 2A). Additionally, saturation curves
were constructed for the two samples by subsampling
the reads from each library and determining the num-
ber of genes detected. As shown in Fig. 2B, the curves of
the two samples reached saturation at approximately 5
million sequenced reads at almost identical rates.
Detection of differentially expressed genes
The DEGseq program was used to statistically analyze
the differentially expressed genes between the two
samples (Wang et al. 2010). In total, 6684 genes were
found to be differentially expressed between the two
samples, of which 3126 genes were up-regulated and
3558 genes were down-regulated in the AT sample
compared to the UT sample. These data indicate that
AuNRs may cause potential alterations to cellular
functions by regulating mRNA transcript levels after
entering MDA-MB-231 cells.
Functional classiﬁcation of differentially
expressed genes
The genes that were found to be differentially expressed
between the two samples were categorized into Gene
Fig. 1 Observation of AuNR
uptake into MDA-MB-231
cells. A TEM image displaying
the size and shape of the
AuNRs. The scale bar
represents 100 nm. B MDA-
MB-231 cells were incubated
with 50 lmol/L AuNRs for
24 h, and the intracellular
AuNRs were observed with a
two-photon ﬂuorescence
confocal microscope. The scale
bar represents 5 lm
Table 2 Reads mapping summary
UT AT
Reads1 18,788,088 23,670,269
Reads1 mapped 15,343,841 19,286,241
% 81.67 81.48
Reads2 18,788,088 23,670,269
Reads2 mapped 15,002,339 18,853,795
% 79.85 79.65
Total unique mapped reads 23,852,032 30,002,220
% 63.48 63.38
Exon region reads 22,689,702 27,902,112
% 60.38 58.94
Intron region reads 3,772,049 5,149,780
% 10.04 10.88
Exon–intron region reads 104,075 118,719
% 0.28 0.25
Table 1 Average quality (AQ) summary of the total reads
Sample UT_1 UT_2 AT_1 AT_2
Raw Data 18,788,088 18,788,088 23,670,269 23,670,269
AQ [26, 40] 17,959,523 17,387,591 22,618,388 21,945,018
% 95.59 92.55 95.56 92.71
AQ [21, 25] 585,577 861,362 726,630 1,066,704
% 3.12 4.58 3.07 4.51
AQ [11, 20] 241,779 523,325 323,542 640,775
% 1.29 2.79 1.37 2.71
AQ [0, 10] 1209 15,810 1709 17,772
% 0.01 0.08 0.01 0.08
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Ontology (GO) categories and fell into three major
groups: cellular component, molecular function, and
biological process. The abundant genes were catego-
rized into 22 major functional groups (percentage of
expressed genes[10) based on the GO categories. The
top six functional categories included cell, organelle,
binding, biological regulation, cellular process, and
metabolic process (Fig. 3). The third level GO categories
were consistent with these results and provided more
information on the cellular functions and subcellular
locations of these genes. The major functional groups
based on these categories included intracellular part,
intracellular organelle part, cytoplasmic part, protein
binding, cellular catabolic process, cellular macro-
molecule localization, gene expression, protein trans-
port, regulation of cell death, and cytoskeleton
organization. In particular, the functional category of
chemoattractant activity included differentially expres-
sed genes that were largely down-regulated (Fig. 3).
These analyses indicate that MDA-MB-231 cells exhibit a
variety of responses to AuNRs and that their movement
capability toward a chemoattractant signal might be
speciﬁcally decreased by AuNR treatment.
Variation of biological pathways in AuNR-treated
MDA-MB-231 cells
The differentially expressed genes described above
were also enriched for pathway analysis based on the
Kyoto Encyclopedia of Genes and Genomes (KEGG)
database. Multiple pathways were signiﬁcantly impac-
ted in AuNR-treated MDA-MB-231 cells, includ-
ing Huntington’s disease, ribosome, spliceosome,
pathways in cancer, RNA degradation, endocytosis,
glycolysis/gluconeogenesis, apoptosis, insulin signaling
pathway, regulation of actin cytoskeleton, etc. As energy
production and the actin cytoskeleton are closely rela-
ted to the chemoattractant activity of metastatic cancer
cells, we further analyzed the glycolysis pathway and
the regulation of the actin cytoskeleton pathway in
AuNR-treated MDA-MB-231 cells.
Glycolysis is mainly an energy conversion pathway
and takes place in the cytosol in eukaryotic cells. In
glycolysis, the six-carbon sugar glucose is oxidized and
split into two halves to create two molecules of pyruvate
(3 carbons each). During glycolysis, the cell produces a
relatively small amount of energy from glucose in the
form of ATP. A net of only 2 ATP molecules are gener-
ated for each glucose molecule that starts down the
glycolytic path. The pyruvate produced during glycolysis
has three potential metabolic fates, to become acetyl-
CoA, ethanol, or lactate. When oxygen is available,
pyruvate can be converted to acetyl-CoA and enter the
TCA cycle where it will be completely oxidized to pro-
duce ATP through oxidative phosphorylation. However,
cancer cells often produce energy through glycolytic
fermentation rather than oxidative phosphorylation.
There are ten enzymes that catalyze the glycolytic steps
that convert glucose into pyruvate. The activity of this
pathway is regulated at key steps to ensure that glucose
consumption and energy production match the needs of
the cell. In mammals, the key regulatory enzyme is
phosphofructokinase (PFK), which catalyzes the rate-
limiting committed reaction of glycolysis. PFK is acti-
vated by AMP and inhibited by ATP; there are also other
regulatory mechanisms that act on PFK. In the AuNR-
treated MDA-MB-231 cells, most of the genes involved
in glycolysis, including pfk, were down-regulated
Fig. 2 Summary of RPKM values of uniquely mapped genes and saturation analyses of the samples. A The RPKM value for each gene was
calculated using uniquely mapped reads. B Each saturation curve was generated by randomly selecting a number of reads from each
sample library and analyzing the number of genes detected. UT untreated MDA-MB-231 cells. AT MDA-MB-231 cells treated with
50 lmol/L AuNRs for 24 h
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(Fig. 4). The down-regulation of those genes may slow
glucose metabolism, reduce energy production, and
result in further potential alterations to cellular func-
tions, such as chemoattractant activity.
The actin cytoskeleton mediates a variety of impor-
tant biological functions in eukaryotic cells. In addition
to providing a structural framework around which cell
shape and polarity are deﬁned, its dynamic properties
provide the driving force for cell mobility, which is
particularly essential for cancer cell migration and
metastasis. The dynamic organization of the actin
cytoskeleton is mainly regulated by small GTPases of the
Rho family, in particular, RhoA, Rac, and CDC42, and
requires an energy supply. Cells receive a variety of
extracellular stimuli: soluble molecules (growth factors,
hormones, and cytokines) that interact with cell surface
receptors; adhesive interactions with the extracellular
matrix; and cell–cell adhesions. These stimuli primarily
regulate the actin cytoskeleton through Rho proteins.
Once activated, Rho GTPases bind to a variety of effec-
tors, including protein kinases and some actin-binding
proteins. These complexes then directly or indirectly
affect the local assembly or disassembly of ﬁlamentous
(F)-actin. In AuNR-treated MDA-MB-231 cells, three
major members of the Rho family (RhoA, Rac, and
CDC42) were down-regulated (Fig. 5), and the down-
regulation of these Rho family members may have
impaired the assembly of the actin cytoskeleton and
related cellular functions, such as chemoattractant
activity.
CONCLUSION
In this study, we investigated the mRNA transcript level
changes of MDA-MB-231 human breast cancer cells
treated with AuNRs employing RNA-seq technology. We
observed the uptake of AuNRs into MDA-MB-231 cells
using two-photon laser confocal microscopy. Then, total
mRNA from AuNR-treated and untreated MDA-MB-231
cells was extracted, and a cDNA library for each sample
was constructed. After Illumina HiSeqTM 2000 sequenc-
ing, transcriptome proﬁles were constructed and bio-
logical analyses were performed. In total, 3126 genes
were found to be up-regulated, and 3558 genes were
found to be down-regulated in AuNR-treated MDA-MB-
231 cells. These genes presumably take part in multiple
biological pathways, including glycolysis and regulation
of the actin cytoskeleton, and impact various cellular
functions, including chemoattractant activity. These
results provide comprehensive insights into the distinct
gene expressionproﬁle ofMDA-MB-231 cells treatedwith
AuNRs and also provide a foundation for further inves-
tigation of the effects of AuNRs on MDA-MB-231 cells.
MATERIALS AND METHODS
Materials
AuNRs synthesized by the seed-mediated growth
method (Wang et al. 2011) were generously provided by
Fig. 3 Functional categorization of differentially expressed genes. Gene Ontology (GO) terms at the 2nd level were plotted here. The
purple and red pillars represent the down-regulated genes and up-regulated genes, respectively
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Fig. 4 Differential gene expression in glycolysis/gluconeogenesis pathway in AuNR-treated MDA-MB-231 cells. Magenta and cyan colors
represent up-regulated and down-regulated genes, respectively. The extent of regulation of the glycolysis/gluconeogenesis pathway
provided by each gene is represented by color grade
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Prof. Xiaochun Wu (National Center for Nanoscience and
Technology). Cell culture medium and fetal bovine
serum (FBS) were purchased from Hyclone (Logan, UT,
USA). Cell culture petri dishes were purchased from BD
Biosciences (San Jose, CA, USA). Other reagents were
manufactured in China and were of analytical grade.
Cell culture
MDA-MB-231 human breast cancer cells obtained from
American Type Culture Collection (ATCC; Manassas, VA,
USA) were cultured in DMEM medium supplemented with
10% FBS, 100 U/mL penicillin, and 100 lg/mL strepto-
mycin at 37 C in a humidiﬁed incubator with 5% CO2.
Observation of AuNRs in MDA-MB-231 cells using
two-photon laser confocal imaging
The size and shape of the AuNRs were characterized
using transmission electron microscopy (TEM, Tecnai
Spirit). To observe AuNRs in MDA-MB-231 cells, MDA-
MB-231 cells were cultured on 35-mm petri dishes for
24 h and treated with 50 lmol/L AuNRs for 24 h. The
cells were then washed with PBS, and fresh complete
medium was added. The cells were observed using laser
scanning microscopy (Olympus BX61W1 with Fluoview
FV1000 software, Japan) with an excitation at 815 nm
using a Maitai two-photon laser (Spectra Physics,
Bozeman, MT, USA), and emission signals were detected
in the green color channel.
Cell treatment for transcriptomic analysis
MDA-MB-231 cells were equally seeded in two 100-mm
cell culture petri dishes. When the cultured cells
reached approximately 65% conﬂuence, one dish of
cells was incubated with 50 lmol/L AuNRs at 37 C for
24 h, while the other dish of cells was left untreated as a
control.
Fig. 5 Different gene expressions in regulation of actin cytoskeleton pathway in AuNR-treated MDA-MB-231 cells. Magenta and cyan
colors represent up-regulated and down-regulated genes, respectively. The extent of regulation of the regulation of actin cytoskeleton
pathway provided by each gene is represented by color grade
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RNA extraction and library construction
For each sample, approximately 5 9 106 cultured cells
were used for the isolation of total RNA with Trizol
Reagent (Life Technologies, Shanghai, China). After
selective depletion of rRNA, high-quality mRNA was
extracted from each sample with an Oligotex mRNA
Midi Kit (Qiagen, Shanghai, China) following the manu-
facturer’s instructions. Subsequently, mRNA was frag-
mented using 109 fragmentation buffer (Ambion,
Austin, TX, USA) and run over a G50 Sephadex column
(USA Scientiﬁc, Ocala, FL, USA) to remove fragmentation
ions. The fragmented mRNA was randomly primed with
hexamers and was reverse-transcribed using a Super-
script II cDNA synthesis kit (Life Technologies). After
second-strand synthesis, end-repair and ligation reac-
tions were performed on the cDNA using paired-end
adapters and ampliﬁcation primers (Illumina, San
Diego, CA, USA). The cDNA library was size-fractionated
on a 2% TAE low-melt agarose gel (Lonza, Basel,
Switzerland), and a slice of the cDNA lane at approxi-
mately 200 bp was selected to build clusters for the
HiSeqTM 2000 sequencing system (Illumina) according
to the manufacturer’s instructions.
Reads mapping
After Illumina HiSeqTM 2000 sequencing with a read
length of 100 bp, raw data from the sequencer were
uploaded to thewapRNA (Zhao et al. 2011), which is a free
web-based application for the processing of high-
throughput RNA-Seq data from NGS platforms, such as
Genome Analyzer of Illumina Inc. (Solexa). Low-quality
reads (with an average quality value below8)were ﬁltered
and the remaining reads were used for the additional
mapping steps.TheHumanEnsembldatabase (version69)
was used as a reference database, and an exon junction
databasewas created by the randomcombination of 92 bp
sequences near the exonic junction points to annotate
transcripts that originated from diverse exons due to
alternative splicing. The BWA program (version 0.6.1-
r104) was used to match-cleaned reads to the Human
Ensembl database and the exon junction database for
annotation successively, with the allowance of 5 mis-
matches for each read (Li and Durbin 2009).
Quantiﬁcation of gene expression level
The gene expression proﬁling analysis was based on the
number of reads matching the exon regions. Genes that
matched more than one read in the exon regions were
considered to be expressed with hour statistical analysis
method. Additionally, the expression value (RPKM, reads
per kilo base of exon model per million mapped reads)
for each gene was calculated to quantify their transcript
levels using uniquely mapped reads (Mortazavi et al.
2008). Saturation curves were generated by randomly
selecting a number of reads from each sample library
and determining the number of genes detected.
DEG detection
The DEGseq program was used to perform the statistical
analysis of the differentiated gene expressions between
the two samples (Wang et al. 2010). Genes with a p value
\0.001 were considered to be distinctly expressed.
Biological analyses
Functional classes were assigned according to GO
mapping provided by the Ensembl database (Yi et al.
2006). The KEGG analysis was based on the results of
the comparison between our mapped genes and the
updated KEGG database (Kanehisa and Goto 2000).
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